Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade-Reference-Cited by-同舟云学术

Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade

Published:2015-10-24 Issue:6 Volume:62 Page:1791-1803
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Guan Dong-Xian¹,Shi Jie²,Zhang Yang³,Zhao Jiang-Sha¹,Long Ling-Yun¹,Chen Tian-Wei¹,Zhang Er-Bin¹,Feng Yuan-Yuan¹,Bao Wen-Dai¹,Deng Yue-Zhen¹,Qiu Lin¹,Zhang Xue-Li⁴,Koeffler H. Phillip⁵⁶,Cheng Shu-qun²,Li Jing-Jing¹,Xie Dong¹

Affiliation:

1. Laboratory of Molecular Oncology; Institute for Nutritional Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Shanghai China

2. Eastern Hepatobiliary Surgery Hospital; Second Military Medical University; Shanghai China

3. The Second Hospital of Anhui Medical University; Hefei China

4. Department of General Surgery of FenXian Hospital; Shanghai China

5. Cancer Science Institute of Singapore; National University of Singapore; Singapore

6. Division of Hematology/Oncology, Cedars-Sinai Medical Center; UCLA School of Medicine; Los Angeles CA

Funder

Ministry of Science and Technology Key Program

National Natural Science Foundation of China

CAS/SAFEA International Partnership Program for Creative Research Teams

Chief Scientist Program, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Publisher

Wiley

Subject

Hepatology

Reference39 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. The role of signaling pathways in the development and treatment of hepatocellular carcinoma;Whittaker;Oncogene,2010

3. Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma;Hwang;Hepatol Res,2004

4. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis;Huynh;BMC Gastroenterol,2003

5. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma;McKillop;Hepatology,1997

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGF21 increases the sensitivity of sorafenib to hepatocellular carcinoma under hypoxia;Malignancy Spectrum;2024-01-05

2. Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study;Signal Transduction and Targeted Therapy;2023-09-27

3. A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability;Cell Death Discovery;2023-09-23

4. Coordinative Activities of STAT3 Inhibitor BP-1-102 and Sorafenib Against Proliferation, Angiogenesis and EMT in Hepatocellular Carcinoma;2023-09-22

5. AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma;Journal of Gastrointestinal Oncology;2023-06